IL17A and neoplasm: A clear involvement of IL-8 has been reported in anti-VEGF tumor resistance in sunitinib-treated renal cell carcinoma.17 Chung et al.33 established a new link of IL-17-driven and stromal cell-mediated signaling that confers resistance to anti-VEGF agents.